Table 4 Cost-effectiveness analysis of no prediction, baseline, MAP and PROMPT prediction

	Comparison for ICER calculation	Costs per person, $	Incremental costs per person screened, $	PE cases	PE cases avoided	ICERs
No prediction	\	2142.63	\	4700	\	\
Baseline prediction	\	2104.60	\	3307	\	\
MAP prediction	\	2096.52	\	3111	\	\
PROMPT prediction	No prediction	2091.29	−51.34	2891	1809	Dominant
	Baseline prediction	\	−13.31	\	416	Dominant
	MAP prediction	\	−5.23	\	380	Dominant

Costs are expressed in US dollars. Incremental costs, ICERs, and PE cases avoided are defined as values per 100,000 people. ICER incremental cost effectiveness ratio, PE preeclampsia, MAP mean arterial pressure.

Quick links

Search